Workup for Pulmonary Embolism
Begin by stratifying clinical probability using a validated prediction rule (Wells or revised Geneva score), then proceed with D-dimer testing in low/intermediate probability patients or direct imaging in high-risk patients—never order D-dimer in hemodynamically unstable patients or those with high clinical probability. 1
Initial Assessment and Risk Stratification
Hemodynamic Status (First Priority)
- Immediately assess for shock or hypotension (systolic BP <90 mmHg or drop ≥40 mmHg for >15 minutes) to identify high-risk PE requiring emergent management 1
- In hemodynamically unstable patients, perform bedside echocardiography or emergency CTPA depending on availability—initiate IV unfractionated heparin with weight-adjusted bolus (80 units/kg) without delay 1, 2
- Massive PE is highly likely when patients present with collapse, unexplained hypoxia, engorged neck veins, or right ventricular gallop 2
Clinical Probability Assessment (Stable Patients)
- Use Wells score or revised Geneva score to categorize patients into low, intermediate, or high clinical probability 1
- Wells score assigns points for: active cancer (+1), paralysis/recent immobilization (+1), bedridden >3 days or major surgery within 4 weeks (+1.5), localized leg tenderness (+1), entire leg swelling (+1), calf swelling >3 cm (+1), pitting edema (+1), collateral superficial veins (+1), previous PE/DVT (+1.5), heart rate >100 (+1.5), hemoptysis (+1), and PE as likely or more likely than alternative diagnosis (+3) 1
- Revised Geneva score includes: previous PE/DVT (+3), heart rate 75-94 (+3) or ≥95 (+5), surgery or fracture within past month (+2), hemoptysis (+2), active cancer (+2), unilateral leg pain (+3), and pain on deep venous palpation/unilateral edema (+4) 1, 2
- Document respiratory rate in all patients—tachypnea >20 breaths/min is present in most PE cases and significantly raises probability 2, 3
Diagnostic Algorithm by Clinical Probability
Low Clinical Probability
- Apply PERC (Pulmonary Embolism Rule-Out Criteria) first in low-risk patients: if all 8 criteria are met (age <50, pulse <100, SaO₂ ≥95%, no hemoptysis, no estrogen use, no prior DVT/PE, no unilateral leg swelling, no surgery/trauma requiring hospitalization within 4 weeks), the risk of PE is lower than testing risks—stop workup 1
- If PERC criteria not met, order highly sensitive D-dimer (preferably Vidas ELISA or equivalent) 1
- D-dimer <500 ng/mL (or age-adjusted: age × 10 ng/mL for patients >50 years) safely excludes PE—no imaging needed, with 3-month thromboembolic risk <1% 1, 2, 4
- If D-dimer elevated, proceed to CTPA 1
Intermediate Clinical Probability
- Order D-dimer testing (do not use PERC criteria in this group) 1
- D-dimer <500 ng/mL (or age-adjusted) excludes PE—no imaging required 1
- If D-dimer elevated, proceed to CTPA 1
- Initiate therapeutic anticoagulation immediately while awaiting imaging results 1, 2
High Clinical Probability
- Proceed directly to CTPA without D-dimer testing—negative D-dimer does not safely exclude PE in this population 1
- Initiate therapeutic anticoagulation immediately before imaging confirmation 1, 2
Imaging Studies
CT Pulmonary Angiography (CTPA)
- CTPA is the first-line imaging modality for hemodynamically stable patients 1
- A normal CTPA in patients with low or intermediate clinical probability definitively excludes PE—no further testing needed 1
- CTPA showing segmental or more proximal filling defect in intermediate/high probability patients confirms PE 1
- In high clinical probability patients with negative CTPA, consider additional testing (leg ultrasound or pulmonary angiography) or specialist consultation 2
Ventilation-Perfusion (V/Q) Scanning
- Use V/Q scan when CTPA is contraindicated (renal failure, contrast allergy, pregnancy) or unavailable 1
- V/Q scan is preferred in younger patients and pregnant women to minimize radiation exposure, particularly breast tissue 1
- Normal perfusion scan excludes PE 1
- High-probability scan with high clinical probability confirms PE 1, 2
- Low-probability scan with low clinical probability excludes PE 2
- All other combinations require CTPA or pulmonary angiography for definitive diagnosis 1, 2
- V/Q scanning should only be used when chest X-ray is normal and patient has no significant cardiopulmonary disease—otherwise results are likely non-diagnostic 2
Lower Extremity Compression Ultrasound
- Perform CUS before CT imaging in patients with clinical signs of DVT, renal failure, contrast allergy, or pregnancy 1, 2
- Proximal DVT on ultrasound confirms VTE—treat with anticoagulation without further pulmonary imaging 1
- Normal ultrasound does not exclude PE (only 30-50% of PE patients have detectable DVT)—proceed to lung imaging if D-dimer elevated 1, 2
Critical Pitfalls to Avoid
- Never order D-dimer in high clinical probability patients—sensitivity is too low and negative result will not obviate need for imaging 1
- Never order D-dimer in hospitalized patients with infection, cancer, inflammation, or recent surgery—false-positive rates exceed 90%, making the test clinically useless 2, 5
- Do not use D-dimer as a standalone test—always combine with validated clinical probability assessment 1, 5
- Never rely on normal oxygen saturation to exclude PE—up to 40% of PE patients have normal SaO₂ 2, 3
- Do not perform CT venography as adjunct to CTPA—adds no diagnostic value 1
- Do not use MRA to rule out PE—insufficient validation 1
- Never use positive D-dimer alone to diagnose PE—confirmation with imaging is always required due to poor specificity (35%) 5
Timing of Diagnostic Testing
- Imaging for massive PE must be performed within 1 hour of presentation 2
- Imaging for non-massive PE should be completed within 24 hours of clinical suspicion 2, 3
- If imaging cannot be obtained within 24 hours in intermediate/high probability patients, continue therapeutic anticoagulation until imaging is available 2
Special Populations
Pregnancy
- Use V/Q scan or CTPA (both safe during pregnancy)—V/Q scan preferred by many to minimize fetal radiation 1
- Consider lower extremity ultrasound first to avoid any radiation if DVT can be confirmed 1
- NOACs are contraindicated in pregnancy—use LMWH or unfractionated heparin 1